Citation Formats
Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. KAYAHAN Et Al. , "Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27, 2011

KAYAHAN, M. Et Al. 2011. Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27 .

KAYAHAN, M., Kadioglu, H., MUSLUMANOGLU, M., IGCI, A., OZMEN, V., IDIZ, O., ... ERALP, Y.(2011). Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27.

KAYAHAN, M. Et Al. "Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27, 2011

KAYAHAN, M. Et Al. "Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27, 2011

KAYAHAN, M. Et Al. (2011) . "Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.27.

@article{article, author={M. KAYAHAN Et Al. }, title={Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}